AI And The New Paradigm Of Drug Discovery

This discussion will examine how AI technologies are revolutionizing each stage of the drug discovery pipeline, creating opportunities to address complex diseases while raising important considerations about validation methodology, regulatory frameworks, and equitable access to innovation.

Join us to discuss:

• How can AI-powered approaches overcome traditional bottlenecks in drug discovery while maintaining scientific rigor and reproducibility?

• What validation frameworks and benchmarks should guide the implementation of AI models in pharmaceutical research and development?

• How might these technological advances bridge the gap between computational predictions and clinical translation to deliver meaningful therapeutic breakthroughs?